Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?

Dabigatran and rivaroxaban, direct oral anticoagulants (DOACs), affect coagulation tests, and knowledge of their effects is important for therapeutic monitoring. Our aim was to examine the association between DOAC levels and routine coagulation tests in patients with nonvalvular atrial fibrillation....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Appl Thromb Hemost
Päätekijät: Silva, Vanessa M., Scanavacca, Maurício, Darrieux, Francisco, Cavalheiro, Cyrillo, Strunz, Celia C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714955/
https://ncbi.nlm.nih.gov/pubmed/30907118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619835053
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia